Our laboratory has previously shown that autophagy (ATG) genes play an important role in host defense against viruses and intracellular bactena. Recently, we developed a potent autophagy-inducing peptide (Tat-Beclin 1) which induces autophagy through disruption of Beclin 1/GAPR-1 complex and which has in vitro antiviral and antibacterial activity and improves clinical outcomes in mice infected with chikungunya virus and West Nile virus (Shoji-Kawata et al. Nature 2013). The overall goals of this proiect will be to develop a semioptimized lead compound with broad-spectrum anti-infective activity based on the autophagy-inducing peptide, Tat-Beclin 1, and/or disruption of the interaction between Beclin 1/GAPR-1. and to identify new drugable host targets that upregulate viral autophagy. These goals will be accomplished in four specific aims.
In aim 1, we will use an iterative process involving structure-based design peptide-mutation analysis, and synthetic chemistry to develop a peptide-like molecule with optimized stability, autophagy-inducing activity, and anti-infective activity, and we will also evaluate whether Tat-Beclin 1 has anti-infective activity in animal models of tuberculosis (this project) and S. Typhimurium (Project 2) and T. gondii (Project 3).
In aim 2, we will further characterize the Beclin 1/GAPR-1 interaction and the biological functions of GAPR-1 in autophagy regulation and antimicrobial host defense.
In aim 3, will perform a genome-wide siRNA screen to identify genes that regulate virus-induced autophagy, using Sindbis virus as a model for positive-strand viruses that are potential agents of biothreat, such as chikungunya and West Nile virus, and we will identify the mechanisms of action of such genes and their antiviral roles in mouse models of chikungunya and West Nile virus pathogenesis.
In aim 4, we will evaluate the efficacy of autophagy-inducing small molecule compounds identified in Project 4 in inhibiting chikungunya virus. West Nile virus, and M. tb replication in vitro and in decreasing West Nile virus, chikungunya virus, and M. tb pathogenesis in mice. Thus, by further development of an autophagy-inducing peptide that already has known in vivo activity against West Nile virus and chikungunya virus, combined with a genome-wide screen to identify new host genes that regulate virus-induced autophagy, combined with testing autophagy-inducing small molecule compounds identified in other projects of this CETR for efficacy in the treatment of West Nile virus and chikungunya virus infection, we will use a multi-pronged and collaborative approach to identify candidate autophagy-inducing compounds with broad-spectrum anti-infective activity against viruses and intracellular pathogens

Public Health Relevance

The development of therapeutics that prevent infection by a broad range of pathogens is an urgent and unmet need for drug discovery. The project will use several concurrent approaches to lead to the development of such drugs, focused both on optimizing existing strategies discovered by our laboratory and on discovering new strategies which are designed to upregulate, the broad-spectrum anti-infective host innate immunity pathway called autophagy

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI109725-04
Application #
9231382
Study Section
Special Emphasis Panel (ZAI1-LR-M)
Project Start
Project End
Budget Start
2017-03-01
Budget End
2018-02-28
Support Year
4
Fiscal Year
2017
Total Cost
$1,748,997
Indirect Cost
Name
Washington University
Department
Type
Domestic Higher Education
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Theisen, Derek J; Davidson 4th, Jesse T; Briseño, Carlos G et al. (2018) WDFY4 is required for cross-presentation in response to viral and tumor antigens. Science 362:694-699
Mohanan, Vishnu; Nakata, Toru; Desch, A Nicole et al. (2018) C1orf106 is a colitis risk gene that regulates stability of epithelial adherens junctions. Science 359:1161-1166
Chiang, Wei-Chung; Wei, Yongjie; Kuo, Yi-Chun et al. (2018) High-Throughput Screens To Identify Autophagy Inducers That Function by Disrupting Beclin 1/Bcl-2 Binding. ACS Chem Biol 13:2247-2260
Peraro, Leila; Deprey, Kirsten L; Moser, Matthew K et al. (2018) Cell Penetration Profiling Using the Chloroalkane Penetration Assay. J Am Chem Soc 140:11360-11369
Nelson, Christopher A; Wilen, Craig B; Dai, Ya-Nan et al. (2018) Structural basis for murine norovirus engagement of bile acids and the CD300lf receptor. Proc Natl Acad Sci U S A 115:E9201-E9210
Fernández, Álvaro F; Sebti, Salwa; Wei, Yongjie et al. (2018) Disruption of the beclin 1-BCL2 autophagy regulatory complex promotes longevity in mice. Nature 558:136-140
Radke, Joshua B; Burrows, Jeremy N; Goldberg, Daniel E et al. (2018) Evaluation of Current and Emerging Antimalarial Medicines for Inhibition of Toxoplasma gondii Growth in Vitro. ACS Infect Dis 4:1264-1274
Thackray, Larissa B; Handley, Scott A; Gorman, Matthew J et al. (2018) Oral Antibiotic Treatment of Mice Exacerbates the Disease Severity of Multiple Flavivirus Infections. Cell Rep 22:3440-3453.e6
Lassen, Kara G; Xavier, Ramnik J (2018) Mechanisms and function of autophagy in intestinal disease. Autophagy 14:216-220
Graham, Daniel B; Luo, Chengwei; O'Connell, Daniel J et al. (2018) Antigen discovery and specification of immunodominance hierarchies for MHCII-restricted epitopes. Nat Med 24:1762-1772

Showing the most recent 10 out of 97 publications